By Sriparna Roy (Reuters) -Akero Therapeutics shares gained 106% before the bell on Monday, after its lead drug showed it can ...

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Mefenamic acid, a common anti-inflammatory drug already approved for pain management, has been found to significantly reduce ...

Patients with metabolic dysfunction-associated steotohepatitis (MASH) who are already taking a glucagon-like peptide-1 ...

Discover how tirzepatide, a diabetes drug, offers hope for congenital generalized lipodystrophy (CGL) treatment, potentially ...

GATC West Virginia played a role in a groundbreaking AI-powered analysis of a new cancer drug in development — an analysis that saved inestimable hours and dollars for the client. \Calif.-based GATC ...

GV Research Platform (GVRP), a leading provider of preclinical research solutions, has announced a strategic partnership with ...

The effects of edible cannabis can take anywhere from 30 minutes to 2 hours to kick in and last anywhere from 4 to 12 hours ...

Fatty liver disease, or hepatic steatosis, occurs when excess fat accumulates in liver cells. Commonly associated with ...

The FDA has accepted for review the New Drug Application for plozasiran for the treatment for familial chylomicronemia syndrome.

A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...